Literature DB >> 17691073

Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation.

Maria Chiara Monti1, Agostino Casapullo, Claudio N Cavasotto, Assunta Napolitano, Raffaele Riccio.   

Abstract

Several marine terpenoids that contain at least one reactive aldehyde group, such as manoalide and its congeners, possess interesting anti-inflammatory activities that are mediated by the covalent inactivation of secretory phospholipase A(2) (sPLA(2)). Scalaradial, a 1,4-dialdehyde marine terpenoid that was isolated from the sponge Cacospongia mollior, is endowed with a relevant anti-inflammatory profile, both in vitro and in vivo, through selective sPLA(2) inhibition. Due to its peculiar dialdehyde structural feature, it has been proposed that scalaradial exerts its enzymatic inactivation by means of an irreversible covalent modification of its target. In the context of our on-going research on anti-PLA(2) natural products and their interaction at a molecular level, we studied scalaradial in an attempt to shed more light on the molecular mechanism of its PLA(2) inhibition. A detailed analysis of the reaction profile between scalaradial and bee venom PLA(2), a model sPLA(2) that shares a high structural homology with the human synovial enzyme, was performed by a combination of spectroscopic techniques, chemical reactions (selective modifications, biomimetic reactions), and classical protein chemistry (such as proteolytic digestion, HPLC and mass spectrometry), along with molecular modeling studies. Unexpectedly, our data clearly indicated the noncovalent forces to be the leading event in the PLA(2) inactivation process; thus, the covalent modification of the enzyme emerges as only a minor side event in the ligand-enzyme interaction. The overall picture might be useful in the design of SLD analogues as new potential anti-inflammatory compounds that target sPLA(2) enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691073     DOI: 10.1002/cbic.200700217

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Mastering tricyclic ring systems for desirable functional cannabinoid activity.

Authors:  Ravil R Petrov; Lindsay Knight; Shao-Rui Chen; Jim Wager-Miller; Steven W McDaniel; Fanny Diaz; Francis Barth; Hui-Lin Pan; Ken Mackie; Claudio N Cavasotto; Philippe Diaz
Journal:  Eur J Med Chem       Date:  2013-09-29       Impact factor: 6.514

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Computational and experimental studies of the interaction between phospho-peptides and the C-terminal domain of BRCA1.

Authors:  Victor M Anisimov; Arturas Ziemys; Smitha Kizhake; Ziyan Yuan; Amarnath Natarajan; Claudio N Cavasotto
Journal:  J Comput Aided Mol Des       Date:  2011-11-16       Impact factor: 3.686

4.  2,3-Dihydro-1-benzofuran derivatives as a series of potent selective cannabinoid receptor 2 agonists: design, synthesis, and binding mode prediction through ligand-steered modeling.

Authors:  Philippe Diaz; Sharangdhar S Phatak; Jijun Xu; Frank R Fronczek; Fanny Astruc-Diaz; Charles M Thompson; Claudio N Cavasotto; Mohamed Naguib
Journal:  ChemMedChem       Date:  2009-10       Impact factor: 3.466

5.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

6.  Pharmacological characterization of cnidarian extracts from the Caribbean Sea: evaluation of anti-snake venom and antitumor properties.

Authors:  Cláudia S Oliveira; Cleópatra A S Caldeira; Rafaela Diniz-Sousa; Dolores L Romero; Silvana Marcussi; Laura A Moura; André L Fuly; Cicília de Carvalho; Walter L G Cavalcante; Márcia Gallacci; Maeli Dal Pai; Juliana P Zuliani; Leonardo A Calderon; Andreimar M Soares
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-08-28

7.  Homology modeling a fast tool for drug discovery: current perspectives.

Authors:  V K Vyas; R D Ukawala; M Ghate; C Chintha
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.